Home › Stem Cells

Stem Cells

News Story
5/4/2017
Posted by Mark Reback
California’s stem cell agency is on the hunt for a new president and CEO after the surprise announcement this week that C. Randal Mills will be departing the California Institute for Regenerative Medicine. He will leave at the end of June. Mills, who has headed the agency for three years, will become the next president and CEO of the...
News Story
5/2/2017
Posted by Mark Reback
California’s $3 billion stem cell agency, which is nearing the end of its financial life, announced Tuesday it is losing its president as the agency enters what some describe as the “last stage” of its 12-year operation. The departure of C. Randal Mills, who joined the agency three years ago, came as an unwelcome surprise to...
News Story
4/26/2017
Posted by Mark Reback
Major investment in regenerative medicine enters its last stage — and the money might run out before treatments are ready. When California voters approved US$3 billion in funding for stem-cell research in 2004, biologists flocked to the state, and citizens dreamed of cures for Parkinson’s disease and spinal-cord injuries. Now, the...
News Story
1/17/2017
Posted by Mark Reback
Evangelina Padilla-Vaccaro – a pink bow in her hair – was likely the first 6-year-old ever to address the leaders of California’s $3 billion stem cell research program. “Thank you,” she whispered. Her mother said more: “Thank you for keeping my family complete.” Alysia Padilla-Vaccaro’s voice cracked...
News Story
9/1/2016
Posted by Mark Reback
The former president of the $3 billion California stem cell agency received $443,500 in total compensation from the Bay Area stem cell company that appointed him to its board of directors only seven days after he left his state post. The stock and cash were provided over a two-year period to Alan Trounson by Newark-based StemCells Inc., a firm...
News Story
12/10/2015
Posted by Mark Reback
A startup company could cherry pick some of the best stem cell projects bankrolled by California taxpayers as part of an ambitious — and risky — plan from the state's stem cell research funding agency. The California Institute for Regenerative Medicine would put as much as $75 million into the venture, matched dollar-for-dollar by...
News Story
2/22/2015
Posted by Mark Reback
The main architect of California's groundbreaking 2004 stem cell initiative has proposed a $100 billion international bond program in life sciences, to speed up research and clinical testing of disease therapies. The program would be focused on stem cells and genomics. Bob Klein, a real estate developer who spearheaded the creation of the...
News Story
12/11/2014
Posted by Mark Reback
The first life that California's stem cell research funding agency saves may be its own. With the clock ticking 10 years and $2.2 billion into an as-yet-unfulfilled quest for new cures, the San Francisco-based California Institute of Regenerative Medicine is overhauling itself with a new, business-friendly approach aimed at speeding therapies...
News Story
11/3/2014
Posted by Mark Reback
A nonprofit advocacy group has asked the U.S. Supreme Court to overturn a decision by the Court of Appeals for the Federal Circuit that barred the group from challenging the validity of a controversial embryonic stem cell patent. Consumer Watchdog, represented by the Public Patent Foundation, filed a petition for certiorari Friday, asking the...
News Release
10/31/2014
Posted by John M. Simpson
WASHINGTON, DC – Consumer Watchdog and the Public Patent Foundation today asked the U.S Supreme Court to overturn a lower court’s decision and allow the two public interest groups to seek the cancellation of a patent on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF). In its petition, Consumer...